Management Team

AMAL Therapeutics is led by a dedicated team with a strong background in molecular and cellular biotechnology R&D gained from working within start-ups, at renowned Academic Institutes, as well as large pharma companies.

 

Dr Madiha Derouazi
Founder and CEO
Laurence de Schoulepnikoff
Chief Operating Officer
Dr Thomas Bogenrieder
Chief Clinical Officer
Dr Keith Wilson
VP CMC & Manufacturing
Dr Elodie Belnoue
Senior Director - in vivo Research
Dr Jean-Francois Mayol
Head of Translational Research
Dr Marie-Laure Santiago-Raber
Head of Non-Clinical Development